Page 3 - Kiran Mazumdar-shaw

Covid-19: We need a shift to sustainability, says Kiran Majumdar-Shaw

The pandemic has thrown us into the deep end in terms of using technology, and that is a positive development, says Shaw

IT services to remain significant to India's job environment: TCS CEO

He added that this is on account of the demand for talent and services, which is "only going to explode given the role that technology is playing today and in future"

Biocon-Mylan launch insulin Glargine at lowest price in US market

The commercialisation in the US of the drug, which already has approval in 45 countries, gives a boost to Biocon's ambitious target of $1 billion in sales through its biologics division by FY22

Biocon chairperson Kiran Mazumdar-Shaw tests positive for Covid-19

Shaw adds to the list of high-profile people who have been tested positive in Bengaluru in a span of few weeks, including Karnataka chief minister B S Yediyurappa

Infosys independent director Bobby Parikh fined for stock market trade

Parikh was appointed as an Independent Director of Infosys effective July 15, 2020, based on the recommendations of the Nomination and Remuneration Committee of the Board

Self-reliance to determine how high flag of freedom flies, says India Inc

Welcoming the National Digital Health Mission, Biocon CMD Kiran Mazumdar Shaw said it gives India's healthcare sector a digital backbone

Russia isn't world's first to develop Covid-19 vaccine: Kiran Mazumdar-Shaw

"If launching a vaccine prior to completion of Phase 3 trials is acceptable to Russia, well so be it," Mazumdar-Shaw said

Itolizumab to be a blockbuster opportunity for Biocon: Kiran Mazumdar-Shaw

We felt that this was the drug that would actually have a role to play in dealing with the cytokine storm that is being seen in Covid-19 patients, says Shaw

Biocon Q1 pre-tax profit declines 21% to Rs 252.30 crore, revenue up 14%

High R&D spend, low profitability in research services due to Covid-19 pull down net profit

Cheer in Covid times

Here's the backstory of Biocon's Alzumab which has been approved by the CDSCO for the treatment of Covid-19 in India

Biocon's Kiran Mazumdar-Shaw named EY World Entrepreneur of 2020

Shaw was picked from among 46 award winners from 41 countries and territories vying for the global title

Biocon MD Kiran Mazumdar-Shaw named EY World Entrepreneur Of The Year

The Biocon MD was picked from among 46 nominations from 41 countries

Vaccine for Covid-19 will take long time to be ready: Kiran Mazumdar-Shaw

The quickest for any vaccine to be prepared is not less than four years, says Kiran Mazumdar-Shaw.

Biocon's Q4 revenue hit by Covid-19 crisis, pre-tax profit declines 28%

The net profit for the period declined 42.2 per cent to Rs 123 crore on YoY basis, according to a BSE filing by the company

India Inc wants govt to shift focus to economy amid Covid-19 outbreak

CEOs warn of economic depression, say need to work within new normal

Covid-19 will reboot world into virtual reality: Kiran Mazumdar-Shaw

This Covid-19 outbreak is a lesson that technology has many faces and being besotted with only one application of computational science is dangerous, Mazumdar-Shaw said

Lockdown extension: Put cash in hands of poor, Chidambaram tells govt

PM Modi said that the fight against Covid-19 could be successful only if the citizens cooperate and maintain the discipline

Actual number of Covid-19 cases 4 times the official count: Mazumdar-Shaw

She also stressed on the need for random testing and making wearing of masks mandatory for everyone

Build to last

In the second part of a series, the author notes down some lessons for start-ups

Efforts on to develop antibody-based test kits for Covid-19: Biocon CMD

She also emphasises on the need for a Covid-19 database and more R&D investment towards communicable diseases to be future-ready